BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32860921)

  • 1. Mycophenolate mofetil for the treatment of cutaneous lichen planus: A retrospective case series.
    Hrin ML; Bashyam AM; Huang WW; Feldman SR
    J Am Acad Dermatol; 2021 Apr; 84(4):1091-1094. PubMed ID: 32860921
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil in erosive genital lichen planus: a case and review of the literature.
    Deen K; McMeniman E
    J Dermatol; 2015 Mar; 42(3):311-4. PubMed ID: 25583369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil.
    Nousari HC; Goyal S; Anhalt GJ
    Arch Dermatol; 1999 Nov; 135(11):1420-1. PubMed ID: 10566854
    [No Abstract]   [Full Text] [Related]  

  • 4. Lichen planus in association with adult-onset still's disease successfully treated with mycophenolate mofetil.
    Emad Y; Ragab Y; El-Shaarawy N
    J Rheumatol; 2012 Jun; 39(6):1305-6. PubMed ID: 22661425
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of severe lichen planus with mycophenolate mofetil.
    Frieling U; Bonsmann G; Schwarz T; Luger TA; Beissert S
    J Am Acad Dermatol; 2003 Dec; 49(6):1063-6. PubMed ID: 14639385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of lichen planopilaris with mycophenolate mofetil.
    Tursen U; Api H; Kaya T; Ikizoglu G
    Dermatol Online J; 2004 Jul; 10(1):24. PubMed ID: 15347506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulcerative lichen planus: a case responding to recombinant platelet-derived growth factor BB and immunosuppression.
    Wollina U; Konrad H; Graefe T
    Acta Derm Venereol; 2001; 81(5):364-5. PubMed ID: 11800147
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessing the clinical effectiveness of an algorithmic approach for mucosal lichen planus (MLP): A retrospective review.
    Ashack KA; Haley LL; Luther CA; Riemer CA; Ashack RJ
    J Am Acad Dermatol; 2016 Jun; 74(6):1073-1076.e2. PubMed ID: 27185423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Patterns for Hydroxychloroquine, Methotrexate, and Mycophenolate Mofetil in Lichen Planopilaris: A Retrospective Chart Review.
    Williams J; Lacy A; Ranpariya VK; Pichardo RO
    J Cutan Med Surg; 2023; 27(4):403-405. PubMed ID: 37559372
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycophenolate mofetil versus methotrexate for vulvar lichen planus: A 10-year retrospective cohort study demonstrates comparable efficacy and tolerability.
    Hrin ML; Bowers NL; Feldman SR; Huang WW; Pichardo RO
    J Am Acad Dermatol; 2022 Aug; 87(2):436-438. PubMed ID: 34499996
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of oral erosive lichen planus with mycophenolate mofetil.
    Dalmau J; Puig L; Roé E; Peramiquel L; Campos M; Alomar A
    J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):259-60. PubMed ID: 17243970
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients.
    Wee JS; Shirlaw PJ; Challacombe SJ; Setterfield JF
    Br J Dermatol; 2012 Jul; 167(1):36-43. PubMed ID: 22309851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of systemic mycophenolate mofetil with topical clobetasol in lichen planopilaris: a parallel-group, assessor- and analyst-blinded, randomized controlled trial.
    Lajevardi V; Ghodsi SZ; Goodarzi A; Hejazi P; Azizpour A; Beygi S
    Am J Clin Dermatol; 2015 Aug; 16(4):303-311. PubMed ID: 25786714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cutaneous lichen planus (part 2): a review of systemic therapies.
    Thandar Y; Maharajh R; Haffejee F; Mosam A
    J Dermatolog Treat; 2019 Nov; 30(7):633-647. PubMed ID: 30451042
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical efficacy of mychophenolate mofetil in treating lichen planopilaris.
    Azizpour A; Hatami P; Lajevardi V; Mohammadi M; Aryanian Z; Mohandesi NA
    Dermatol Ther; 2022 Aug; 35(8):e15625. PubMed ID: 35674693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of mycophenolate mofetil for lichen planopilaris.
    Cho BK; Sah D; Chwalek J; Roseborough I; Ochoa B; Chiang C; Price VH
    J Am Acad Dermatol; 2010 Mar; 62(3):393-7. PubMed ID: 20061053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of progressive skin involvement following discontinuation or dose reduction of Mycophenolate Mofetil treatment in patients with diffuse Systemic Sclerosis.
    Mendoza FA; Lee-Ching C; Jimenez SA
    Semin Arthritis Rheum; 2020 Feb; 50(1):135-139. PubMed ID: 31311679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus.
    Byrd JA; Davis MD; Rogers RS
    Arch Dermatol; 2004 Jun; 140(6):715-20. PubMed ID: 15210463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolic acid in dermatology a century after its discovery.
    Strathie Page SJ; Tait CP
    Australas J Dermatol; 2015 Feb; 56(1):77-83. PubMed ID: 25557632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.